Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [466]

Metastatic melanoma: changes in epidemiology and current standards of care (1/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof...

Metastatic melanoma: changes in epidemiology and current standards of care (1/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: ipilimumab (2/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof...

Recent advances in advanced melanoma: ipilimumab (2/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: BRAF inhibitors (3/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof...

Recent advances in advanced melanoma: BRAF inhibitors (3/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Combination of newer agents in advanced melanoma (4/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof...

Combination of newer agents in advanced melanoma (4/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Guidelines and recommendations for advanced melanoma (5/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof...

Guidelines and recommendations for advanced melanoma (5/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Improving pre-clinical experimental models to test anti cancer drugs

Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada

Improving pre-clinical experimental models to test anti cancer drugs ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )

Early stage molecular profiling

Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA

Early stage molecular profiling ( Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA )

Emergence of ipilimumab and vemurafenib for melanoma

Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker

Emergence of ipilimumab and vemurafenib for melanoma ( Prof Reinhard Dummer, Prof Claus Garbe, Dr Caroline Robert, Prof Jürgen Becker )

The P-Medicine project; data sharing and integration for personalised medicine

Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland

The P-Medicine project; data sharing and integration for personalised medicine ( Dr Simona Rossi - Swiss Institute for Bioinformatics, Lausanne, Switzerland )

The changing landscape of melanoma therapies: indications of better patient...

Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof...

The changing landscape of melanoma therapies: indications of better patient outcome ( Prof Alexander Eggermont, Dr Caroline Robert, Prof John Haanen and Prof Reinhard Dummer )

Role of vemurafenib in melanoma treatment

Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK

Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )

Combining oral targeted therapies shows early anti-tumour activity for advanced...

Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA

Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer